As breast cancer awareness month be...

As breast cancer awareness month begins in the UK the European Agency for the Evaluation of Medicinal produces (EMEA) has announced that it is to investigate the association between hormone replacement therapy (HRT) and the disease in light of the unwilted concerns about the link.

As reported in last month's Cancer Nursing Practice, issues from the Million Women application of mind show that HRT can double the chances of developing breast cancer. If EMEA thinks HRT to be a public health risk, the agency could journey so far as removing it from the market.

In the meantime, the President of the